Thalidomide

Thalidomide

SCHEMBL28144673

O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1.O=C1CCCC(=O)N1

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CRBNCUL4ADDB1RBX1

The experimentally established mechanism targets of Thalidomide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CRBN known ✓ Q96SW2 19/20 0.88
DDB1 known ✓ Q16531 15/20 0.88
IKZF3 Q9UKT9 2/20 0.88
ALDH1A1 P00352 1/20 0.88
CHRM2 P08172 1/20 0.88
OPRM1 P35372 1/20 0.88
CYP1A2 P05177 1/20 0.88
TSHR P16473 1/20 0.88
TDP1 Q9NUW8 1/20 0.88
TNF P01375 1/20 0.67
IL1B P01584 1/20 0.67
TBXA2R P21731 1/20 0.67
IKZF1 Q13422 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thalidomide SCHEMBL410642 0.94 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
Thalidomide SCHEMBL411175 0.94 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
Thalidomide SCHEMBL41641 0.94 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
Thalidomide SCHEMBL7581 0.94 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
Thalidomide SCHEMBL411178 0.94 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
Thalidomide SCHEMBL455269 0.94 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
Thalidomide SCHEMBL15197560 0.94 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
Thalidomide SCHEMBL571278 0.94 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
Thalidomide SCHEMBL23420695 0.92 CRBN (0.97) CRBNDDB1IKZF3ALDH1A1CHRM2
Thalidomide SCHEMBL22772286 0.92 CRBN (0.97) CRBNDDB1IKZF3ALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101945892-B Methods and reagents for improved targeting of CD138 expressing tumor cells 生物测试股份公司 2017-11-24 CN disclosed
CN-102573916-B Uses of immunoconjugates targeting cd138 生物测试股份公司 2017-05-17 CN disclosed